Global Opioids Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025


  • Mar 2020
  • |
  • 106
  • |
  • Pharmaceuticals and Healthcare

Market Overview
The global Opioids market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 2.4% in the forecast period of 2020 to 2025 and will expected to reach USD 16810 million by 2025, from USD 15260 million in 2019.
The Opioids market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Opioids market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Opioids
market has been segmented into
Immediate-Release/Short-Acting Opioid
Extended-Release/Long-Acting Opioid
By Application, Opioids has been segmented into:
Pain Relief
Anesthesia
Cough Suppression
Diarrhea Suppression
Deaddiction

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Opioids market presented in the report. This section sheds light on the sales growth of different regional and country-level Opioids markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Opioids market.
The report offers in-depth assessment of the growth and other aspects of the Opioids market in
important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Opioids Market Share Analysis
Opioids competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Opioids sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Opioids sales, revenue and market share for each player covered in this report.

The major players covered in Opioids are:
Purdue Pharma L.P.
Pfizer, Inc.
West-Ward Pharmaceuticals Corporation
Sun Pharmaceutical Industries Limited.
Allergan
Egalet Corporation
Janssen Pharmaceuticals, Inc.
Among other players domestic and global, Opioids market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Our analysts understand competitive strengths and provide competitive analysis for each competitor separately.


The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Opioids product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Opioids, with price, sales, revenue and global market share of Opioids in 2018 and 2019.
Chapter 3, the Opioids competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Opioids breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Opioids market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Opioids sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents



1 Market Overview

1.1 Opioids Introduction

1.2 Market Analysis by Type

1.2.1 Overview: Global Opioids Revenue by Type: 2015 VS 2019 VS 2025

1.2.2 Immediate-Release/Short-Acting Opioid

1.2.3 Extended-Release/Long-Acting Opioid

1.3 Market Analysis by Application

1.3.1 Overview: Global Opioids Revenue by Application: 2015 VS 2019 VS 2025

1.3.2 Pain Relief

1.3.3 Anesthesia

1.3.4 Cough Suppression

1.3.5 Diarrhea Suppression

1.3.6 Deaddiction

1.4 Overview of Global Opioids Market

1.4.1 Global Opioids Market Status and Outlook (2015-2025)

1.4.2 North America (United States, Canada and Mexico)

1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)

1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.5 South America, Middle East & Africa

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Purdue Pharma L.P.

2.1.1 Purdue Pharma L.P. Details

2.1.2 Purdue Pharma L.P. Major Business and Total Revenue (Financial Highlights) Analysis

2.1.3 Purdue Pharma L.P. SWOT Analysis

2.1.4 Purdue Pharma L.P. Product and Services

2.1.5 Purdue Pharma L.P. Opioids Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.2 Pfizer, Inc.

2.2.1 Pfizer, Inc. Details

2.2.2 Pfizer, Inc. Major Business and Total Revenue (Financial Highlights) Analysis

2.2.3 Pfizer, Inc. SWOT Analysis

2.2.4 Pfizer, Inc. Product and Services

2.2.5 Pfizer, Inc. Opioids Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.3 West-Ward Pharmaceuticals Corporation

2.3.1 West-Ward Pharmaceuticals Corporation Details

2.3.2 West-Ward Pharmaceuticals Corporation Major Business and Total Revenue (Financial Highlights) Analysis

2.3.3 West-Ward Pharmaceuticals Corporation SWOT Analysis

2.3.4 West-Ward Pharmaceuticals Corporation Product and Services

2.3.5 West-Ward Pharmaceuticals Corporation Opioids Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.4 Sun Pharmaceutical Industries Limited.

2.4.1 Sun Pharmaceutical Industries Limited. Details

2.4.2 Sun Pharmaceutical Industries Limited. Major Business and Total Revenue (Financial Highlights) Analysis

2.4.3 Sun Pharmaceutical Industries Limited. SWOT Analysis

2.4.4 Sun Pharmaceutical Industries Limited. Product and Services

2.4.5 Sun Pharmaceutical Industries Limited. Opioids Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.5 Allergan

2.5.1 Allergan Details

2.5.2 Allergan Major Business and Total Revenue (Financial Highlights) Analysis

2.5.3 Allergan SWOT Analysis

2.5.4 Allergan Product and Services

2.5.5 Allergan Opioids Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.6 Egalet Corporation

2.6.1 Egalet Corporation Details

2.6.2 Egalet Corporation Major Business and Total Revenue (Financial Highlights) Analysis

2.6.3 Egalet Corporation SWOT Analysis

2.6.4 Egalet Corporation Product and Services

2.6.5 Egalet Corporation Opioids Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.7 Janssen Pharmaceuticals, Inc.

2.7.1 Janssen Pharmaceuticals, Inc. Details

2.7.2 Janssen Pharmaceuticals, Inc. Major Business and Total Revenue (Financial Highlights) Analysis

2.7.3 Janssen Pharmaceuticals, Inc. SWOT Analysis

2.7.4 Janssen Pharmaceuticals, Inc. Product and Services

2.7.5 Janssen Pharmaceuticals, Inc. Opioids Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

3 Sales, Revenue and Market Share by Manufacturer

3.1 Global Opioids Sales and Market Share by Manufacturer (2018-2019)

3.2 Global Opioids Revenue and Market Share by Manufacturer (2018-2019)

3.3 Market Concentration Rate

3.3.1 Top 3 Opioids Manufacturer Market Share in 2019

3.3.2 Top 6 Opioids Manufacturer Market Share in 2019

3.4 Market Competition Trend

4 Global Market Analysis by Regions

4.1 Global Opioids Sales, Revenue and Market Share by Regions

4.1.1 Global Opioids Sales and Market Share by Regions (2015-2020)

4.1.2 Global Opioids Revenue and Market Share by Regions (2015-2020)

4.2 North America Opioids Sales and Growth Rate (2015-2020)

4.3 Europe Opioids Sales and Growth Rate (2015-2020)

4.4 Asia-Pacific Opioids Sales and Growth Rate (2015-2020)

4.5 South America Opioids Sales and Growth Rate (2015-2020)

4.6 Middle East and Africa Opioids Sales and Growth Rate (2015-2020)

5 North America by Country

5.1 North America Opioids Sales, Revenue and Market Share by Country

5.1.1 North America Opioids Sales and Market Share by Country (2015-2020)

5.1.2 North America Opioids Revenue and Market Share by Country (2015-2020)

5.2 United States Opioids Sales and Growth Rate (2015-2020)

5.3 Canada Opioids Sales and Growth Rate (2015-2020)

5.4 Mexico Opioids Sales and Growth Rate (2015-2020)

6 Europe by Country

6.1 Europe Opioids Sales, Revenue and Market Share by Country

6.1.1 Europe Opioids Sales and Market Share by Country (2015-2020)

6.1.2 Europe Opioids Revenue and Market Share by Country (2015-2020)

6.2 Germany Opioids Sales and Growth Rate (2015-2020)

6.3 UK Opioids Sales and Growth Rate (2015-2020)

6.4 France Opioids Sales and Growth Rate (2015-2020)

6.5 Russia Opioids Sales and Growth Rate (2015-2020)

6.6 Italy Opioids Sales and Growth Rate (2015-2020)

7 Asia-Pacific by Regions

7.1 Asia-Pacific Opioids Sales, Revenue and Market Share by Regions

7.1.1 Asia-Pacific Opioids Sales and Market Share by Regions (2015-2020)

7.1.2 Asia-Pacific Opioids Revenue and Market Share by Regions (2015-2020)

7.2 China Opioids Sales and Growth Rate (2015-2020)

7.3 Japan Opioids Sales and Growth Rate (2015-2020)

7.4 Korea Opioids Sales and Growth Rate (2015-2020)

7.5 India Opioids Sales and Growth Rate (2015-2020)

7.6 Southeast Asia Opioids Sales and Growth Rate (2015-2020)

7.7 Australia Opioids Sales and Growth Rate (2015-2020)

8 South America by Country

8.1 South America Opioids Sales, Revenue and Market Share by Country

8.1.1 South America Opioids Sales and Market Share by Country (2015-2020)

8.1.2 South America Opioids Revenue and Market Share by Country (2015-2020)

8.2 Brazil Opioids Sales and Growth Rate (2015-2020)

8.3 Argentina Opioids Sales and Growth Rate (2015-2020)

9 Middle East & Africa by Countries

9.1 Middle East & Africa Opioids Sales, Revenue and Market Share by Country

9.1.1 Middle East & Africa Opioids Sales and Market Share by Country (2015-2020)

9.1.2 Middle East & Africa Opioids Revenue and Market Share by Country (2015-2020)

9.2 Saudi Arabia Opioids Sales and Growth Rate (2015-2020)

9.3 Turkey Opioids Sales and Growth Rate (2015-2020)

9.4 Egypt Opioids Sales and Growth Rate (2015-2020)

9.5 South Africa Opioids Sales and Growth Rate (2015-2020)

10 Market Segment by Type

10.1 Global Opioids Sales and Market Share by Type (2015-2020)

10.2 Global Opioids Revenue and Market Share by Type (2015-2020)

10.3 Global Opioids Price by Type (2015-2020)

11 Global Opioids Market Segment by Application

11.1 Global Opioids Sales Market Share by Application (2015-2020)

11.2 Global Opioids Revenue Market Share by Application (2015-2020)

11.3 Global Opioids Price by Application (2015-2020)

12 Market Forecast

12.1 Global Opioids Sales, Revenue and Growth Rate (2021-2025)

12.2 Opioids Market Forecast by Regions (2021-2025)

12.2.1 North America Opioids Market Forecast (2021-2025)

12.2.2 Europe Opioids Market Forecast (2021-2025)

12.2.3 Asia-Pacific Opioids Market Forecast (2021-2025)

12.2.4 South America Opioids Market Forecast (2021-2025)

12.2.5 Middle East & Africa Opioids Market Forecast (2021-2025)

12.3 Opioids Market Forecast by Type (2021-2025)

12.3.1 Global Opioids Sales Forecast by Type (2021-2025)

12.3.2 Global Opioids Market Share Forecast by Type (2021-2025)

12.4 Opioids Market Forecast by Application (2021-2025)

12.4.1 Global Opioids Sales Forecast by Application (2021-2025)

12.4.2 Global Opioids Market Share Forecast by Application (2021-2025)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source

15.3 Disclaimer

15.4 About US

List of Tables



Table 1. Global Opioids Revenue (USD Million) by Type: 2015 VS 2019 VS 2025

Table 2. Breakdown of Opioids by Company Type (Tier 1, Tier 2 and Tier 3)

Table 3. Global Opioids Revenue (USD Million) by Application: 2015 VS 2019 VS 2025

Table 4. Market Opportunities in Next Few Years

Table 5. Market Risks Analysis

Table 6. Market Drivers

Table 7. Purdue Pharma L.P. Basic Information, Manufacturing Base and Competitors

Table 8. Purdue Pharma L.P. Opioids Major Business

Table 9. Purdue Pharma L.P. Opioids Total Revenue (USD Million) (2018-2019)

Table 10. Purdue Pharma L.P. SWOT Analysis

Table 11. Purdue Pharma L.P. Opioids Product and Services

Table 12. Purdue Pharma L.P. Opioids Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

Table 13. Pfizer, Inc. Basic Information, Manufacturing Base and Competitors

Table 14. Pfizer, Inc. Opioids Major Business

Table 15. Pfizer, Inc. Opioids Total Revenue (USD Million) (2018-2019)

Table 16. Pfizer, Inc. SWOT Analysis

Table 17. Pfizer, Inc. Opioids Product and Services

Table 18. Pfizer, Inc. Opioids Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

Table 19. West-Ward Pharmaceuticals Corporation Basic Information, Manufacturing Base and Competitors

Table 20. West-Ward Pharmaceuticals Corporation Opioids Major Business

Table 21. West-Ward Pharmaceuticals Corporation Opioids Total Revenue (USD Million) (2018-2019)

Table 22. West-Ward Pharmaceuticals Corporation SWOT Analysis

Table 23. West-Ward Pharmaceuticals Corporation Opioids Product and Services

Table 24. West-Ward Pharmaceuticals Corporation Opioids Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

Table 25. Sun Pharmaceutical Industries Limited. Basic Information, Manufacturing Base and Competitors

Table 26. Sun Pharmaceutical Industries Limited. Opioids Major Business

Table 27. Sun Pharmaceutical Industries Limited. Opioids Total Revenue (USD Million) (2018-2019)

Table 28. Sun Pharmaceutical Industries Limited. SWOT Analysis

Table 29. Sun Pharmaceutical Industries Limited. Opioids Product and Services

Table 30. Sun Pharmaceutical Industries Limited. Opioids Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

Table 31. Allergan Basic Information, Manufacturing Base and Competitors

Table 32. Allergan Opioids Major Business

Table 33. Allergan Opioids Total Revenue (USD Million) (2018-2019)

Table 34. Allergan SWOT Analysis

Table 35. Allergan Opioids Product and Services

Table 36. Allergan Opioids Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

Table 37. Egalet Corporation Basic Information, Manufacturing Base and Competitors

Table 38. Egalet Corporation Opioids Major Business

Table 39. Egalet Corporation Opioids Total Revenue (USD Million) (2018-2019)

Table 40. Egalet Corporation SWOT Analysis

Table 41. Egalet Corporation Opioids Product and Services

Table 42. Egalet Corporation Opioids Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

Table 43. Janssen Pharmaceuticals, Inc. Basic Information, Manufacturing Base and Competitors

Table 44. Janssen Pharmaceuticals, Inc. Opioids Major Business

Table 45. Janssen Pharmaceuticals, Inc. Opioids Total Revenue (USD Million) (2018-2019)

Table 46. Janssen Pharmaceuticals, Inc. SWOT Analysis

Table 47. Janssen Pharmaceuticals, Inc. Opioids Product and Services

Table 48. Janssen Pharmaceuticals, Inc. Opioids Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

Table 49. Global Opioids Sales by Manufacturer (2018-2019) (MT)

Table 50. Global Opioids Revenue by Manufacturer (2018-2019) (USD Million)

Table 51. Global Opioids Sales by Regions (2015-2020) (MT)

Table 52. Global Opioids Sales Market Share by Regions (2015-2020)

Table 53. Global Opioids Revenue by Regions (2015-2020) (USD Million)

Table 54. North America Opioids Sales by Countries (2015-2020) (MT)

Table 55. North America Opioids Sales Market Share by Countries (2015-2020)

Table 56. North America Opioids Revenue by Countries (2015-2020) (USD Million)

Table 57. North America Opioids Revenue Market Share by Countries (2015-2020)

Table 58. Europe Opioids Sales by Countries (2015-2020) (MT)

Table 59. Europe Opioids Sales Market Share by Countries (2015-2020)

Table 60. Europe Opioids Revenue by Countries (2015-2020) (USD Million)

Table 61. Asia-Pacific Opioids Sales by Regions (2015-2020) (MT)

Table 62. Asia-Pacific Opioids Sales Market Share by Regions (2015-2020)

Table 63. Asia-Pacific Opioids Revenue by Regions (2015-2020) (USD Million)

Table 64. South America Opioids Sales by Countries (2015-2020) (MT)

Table 65. South America Opioids Sales Market Share by Countries (2015-2020)

Table 66. South America Opioids Revenue by Countries (2015-2020) (USD Million)

Table 67. South America Opioids Revenue Market Share by Countries (2015-2020)

Table 68. Middle East & Africa Opioids Sales by Countries (2015-2020) (MT)

Table 69. Middle East & Africa Opioids Sales Market Share by Countries (2015-2020)

Table 70. Middle East & Africa Opioids Revenue by Countries (2015-2020) (USD Million)

Table 71. Middle East & Africa Opioids Revenue Market Share by Countries (2015-2020)

Table 72. Global Opioids Sales by Type (2015-2020) (MT)

Table 73. Global Opioids Sales Share by Type (2015-2020)

Table 74. Global Opioids Revenue by Type (2015-2020) (USD Million)

Table 75. Global Opioids Revenue Share by Type (2015-2020)

Table 76. Global Opioids Sales by Application (2015-2020) (MT)

Table 77. Global Opioids Sales Share by Application (2015-2020)

Table 78. Global Opioids Sales Forecast by Regions (2021-2025) (MT)

Table 79. Global Opioids Market Share Forecast by Regions (2021-2025)

Table 80. Global Opioids Sales Forecast by Type (2021-2025) (MT)

Table 81. Global Opioids Market Share Forecast by Type (2021-2025)

Table 82. Global Opioids Sales Forecast by Application (2021-2025)

Table 83. Global Opioids Market Share Forecast by Application (2021-2025)

Table 84. Direct Channel Pros & Cons

Table 85. Indirect Channel Pros & Cons

Table 86. Distributors/Traders/ Dealers List

List of Figures

Figure 1. Opioids Picture

Figure 2. Global Sales Market Share of Opioids by Type in 2019

Figure 3. Immediate-Release/Short-Acting Opioid Picture

Figure 4. Extended-Release/Long-Acting Opioid Picture

Figure 5. Opioids Sales Market Share by Application in 2018

Figure 6. Pain Relief Picture

Figure 7. Anesthesia Picture

Figure 8. Cough Suppression Picture

Figure 9. Diarrhea Suppression Picture

Figure 10. Deaddiction Picture

Figure 11. Global Opioids Market Status and Outlook (2015-2025) (USD Million)

Figure 12. United States Opioids Revenue (Value) and Growth Rate (2015-2025)

Figure 13. Canada Opioids Revenue (Value) and Growth Rate (2015-2025)

Figure 14. Mexico Opioids Revenue (Value) and Growth Rate (2015-2025)

Figure 15. Germany Opioids Revenue (Value) and Growth Rate (2015-2025)

Figure 16. France Opioids Revenue (Value) and Growth Rate (2015-2025)

Figure 17. UK Opioids Revenue (Value) and Growth Rate (2015-2025)

Figure 18. Russia Opioids Revenue (Value) and Growth Rate (2015-2025)

Figure 19. Italy Opioids Revenue (Value) and Growth Rate (2015-2025)

Figure 20. China Opioids Revenue (Value) and Growth Rate (2015-2025)

Figure 21. Japan Opioids Revenue (Value) and Growth Rate (2015-2025)

Figure 22. Korea Opioids Revenue (Value) and Growth Rate (2015-2025)

Figure 23. India Opioids Revenue (Value) and Growth Rate (2015-2025)

Figure 24. Southeast Asia Opioids Revenue (Value) and Growth Rate (2015-2025)

Figure 25. Australia Opioids Revenue (Value) and Growth Rate (2015-2025) (USD Million)

Figure 26. Brazil Opioids Revenue (Value) and Growth Rate (2015-2025)

Figure 27. Egypt Opioids Revenue (Value) and Growth Rate (2015-2025)

Figure 28. Saudi Arabia Opioids Revenue (Value) and Growth Rate (2015-2025)

Figure 29. South Africa Opioids Revenue (Value) and Growth Rate (2015-2025)

Figure 30. Turkey Opioids Revenue (Value) and Growth Rate (2015-2025)

Figure 31. Global Opioids Sales Market Share by Manufacturer in 2019

Figure 32. Global Opioids Revenue Market Share by Manufacturer in 2019

Figure 33. Top 3 Opioids Manufacturer (Revenue) Market Share in 2019

Figure 34. Top 6 Opioids Manufacturer (Revenue) Market Share in 2019

Figure 35. Key Manufacturer Market Share Trend

Figure 36. Global Opioids Sales and Growth Rate (2015-2020) (MT)

Figure 37. Global Opioids Revenue and Growth Rate (2015-2020) (USD Million)

Figure 38. Global Opioids Revenue Market Share by Regions (2015-2020)

Figure 39. Global Opioids Revenue Market Share by Regions in 2018

Figure 40. North America Opioids Sales and Growth Rate (2015-2020)

Figure 41. Europe Opioids Sales and Growth Rate (2015-2020)

Figure 42. Asia-Pacific Opioids Sales and Growth Rate (2015-2020)

Figure 43. South America Opioids Sales and Growth Rate (2015-2020)

Figure 44. Middle East & Africa Opioids Sales and Growth Rate (2015-2020)

Figure 45. North America Opioids Revenue and Growth Rate (2015-2020) (USD Million)

Figure 46. North America Opioids Sales Market Share by Countries (2015-2020)

Figure 47. North America Opioids Sales Market Share by Countries in 2018

Figure 48. North America Opioids Revenue Market Share by Countries (2015-2020) (USD Million)

Figure 49. North America Opioids Revenue Market Share by Countries in 2018

Figure 50. United States Opioids Sales and Growth Rate (2015-2020) (MT)

Figure 51. Canada Opioids Sales and Growth Rate (2015-2020) (MT)

Figure 52. Mexico Opioids Sales and Growth Rate (2015-2020) (MT)

Figure 53. Europe Opioids Revenue and Growth Rate (2015-2020) (USD Million)

Figure 54. Europe Opioids Revenue Market Share by Countries (2015-2020)

Figure 55. Europe Opioids Revenue Market Share by Countries in 2019

Figure 56. Germany Opioids Sales and Growth Rate (2015-2020) (MT)

Figure 57. UK Opioids Sales and Growth Rate (2015-2020) (MT)

Figure 58. France Opioids Sales and Growth Rate (2015-2020) (MT)

Figure 59. Russia Opioids Sales and Growth Rate (2015-2020) (MT)

Figure 60. Italy Opioids Sales and Growth Rate (2015-2020) (MT)

Figure 61. Asia-Pacific Opioids Revenue and Growth Rate (2015-2020) (USD Million)

Figure 62. Asia-Pacific Opioids Sales Market Share by Regions 2019

Figure 63. Asia-Pacific Opioids Revenue Market Share by Regions 2019

Figure 64. China Opioids Sales and Growth Rate (2015-2020) (MT)

Figure 65. Japan Opioids Sales and Growth Rate (2015-2020) (MT)

Figure 66. Korea Opioids Sales and Growth Rate (2015-2020) (MT)

Figure 67. India Opioids Sales and Growth Rate (2015-2020) (MT)

Figure 68. Southeast Asia Opioids Sales and Growth Rate (2015-2020) (MT)

Figure 69. South America Opioids Revenue and Growth Rate (2015-2020) (USD Million)

Figure 70. South America Opioids Sales Market Share by Countries in 2019

Figure 71. South America Opioids Revenue Market Share by Countries in 2019

Figure 72. Brazil Opioids Sales and Growth Rate (2015-2020) (MT)

Figure 73. Argentina Opioids Sales and Growth Rate (2015-2020) (MT)

Figure 74. Middle East and Africa Opioids Revenue and Growth Rate (2015-2020) (USD Million)

Figure 75. Middle East and Africa Opioids Sales Market Share by Countries in 2019

Figure 76. Middle East and Africa Opioids Revenue Market Share by Countries (2015-2020)

Figure 77. Middle East and Africa Opioids Revenue Market Share by Countries in 2019

Figure 78. Saudi Arabia Opioids Sales and Growth Rate (2015-2020) (MT)

Figure 79. Egypt Opioids Sales and Growth Rate (2015-2020) (MT)

Figure 80. Turkey Opioids Sales and Growth Rate (2015-2020) (MT)

Figure 81. South Africa Opioids Sales and Growth Rate (2015-2020) (MT)

Figure 82. Global Opioids Sales and Growth Rate (2021-2025) (MT)

Figure 83. Global Opioids Revenue and Growth Rate (2021-2025) (USD Million)

Figure 84. North America Sales Opioids Market Forecast (2021-2025) (MT)

Figure 85. Europe Sales Opioids Market Forecast (2021-2025) (MT)

Figure 86. Asia-Pacific Sales Opioids Market Forecast (2021-2025) (MT)

Figure 87. South America Sales Opioids Market Forecast (2021-2025) (MT)

Figure 88. Middle East & Africa Sales Opioids Market Forecast (2021-2025) (MT)

Figure 89. Sales Channel: Direct Channel vs Indirect Channel

Sample Request is not available